Probiotic Compositions for Enzymatic L-DOPA-to-Dopamine Conversion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The lack of understanding of the mechanisms by which probiotics exert their benefits and the inefficiency of chemical synthesis methods for neurochemicals like dopamine limit their widespread use in medicine and industry.
Innovation Solution
Development of synbiotic compositions comprising probiotic strains capable of producing neurochemicals, such as dopamine, using a medium that simulates gastrointestinal conditions, combined with neurochemical precursors like L-DOPA, to enhance their beneficial effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical synthesis methods are used to produce neurochemicals like dopamine, then production efficiency can be improved, but the lack of understanding of probiotic mechanisms limits their widespread use in medicine
Solution Approach 1:
The patent uses a simulated gastrointestinal tract medium as an intermediary system to bridge the gap between probiotic strains and neurochemical production. This medium allows probiotics to be screened and selected based on their ability to produce neurochemicals like dopamine, effectively mediating the translation of probiotic mechanisms into measurable outputs for medical applications
Solution Approach 2:
The patent replaces complex in vivo biological systems with an in vitro simulated gastrointestinal tract medium. This substitution allows for controlled screening of probiotic strains without the complexity of living host systems, enabling systematic study of probiotic mechanisms and neurochemical production
2Reliability
If probiotics are used to treat gastrointestinal inflammation, then therapeutic benefits can be achieved, but the inefficiency of current screening methods limits their application
Solution Approach 1:
The patent segments the gastrointestinal tract into distinct simulated phases (oral, gastric, intestinal) with specific media compositions. This segmentation allows systematic screening of probiotic strains against different gastrointestinal conditions, improving the efficiency of identifying therapeutically relevant strains while maintaining reliability of therapeutic benefits
Solution Approach 2:
The patent employs simulated gastrointestinal media with controlled parameters (pH, enzymes, nutrients) to create reproducible conditions for probiotic screening. By adjusting these parameters to match different gastrointestinal environments, the method efficiently identifies probiotics effective for specific therapeutic conditions without compromising reliability
3Adaptability or versatility
If probiotic strains are screened for neurochemical production, then targeted therapeutic applications can be developed, but the complexity of screening processes increases
Solution Approach 1:
The simulated gastrointestinal tract medium serves multiple functions simultaneously: it simulates different GI phases, provides nutrients for probiotic growth, enables neurochemical production, and allows for strain screening. This multi-functionality achieves targeted application capability while reducing overall screening process complexity by consolidating multiple steps into a single integrated system
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the identification and use of probiotics that produce neurochemicals effectively, treating gastrointestinal inflammation and providing a more efficient method for dopamine production, thereby addressing the limitations of existing technologies.
Implementation Method 1
probiotic strains capable of producing neurochemicals, such as dopamine, using a medium that simulates gastrointestinal conditions, combined with neurochemical precursors like L-DOPA
Data Source
AI summary
The present invention is directed to synbiotic compositions of probiotic strains and prebiotics, along with uses thereof for targeted human and animal applications, for example, in promoting health and well-being and/or treating therapeutic conditions. The present invention is also directed to methods of probiotic selection and detection of strains with the ability to produce neurochemicals in the gastrointestinal tract of a subject, providing a microbial endocrinology-based mechanism and approach for optimization of synbiotic delivery of a probiotic with a neurochemical precursor. Still further the present invention is directed to industrial applications for production of dopamine utilizing methods and media suitable for the same.